Evidence map›Paper›PMID 26857898›Full record

ArticleDrug and alcohol dependence2016

HIV primary care providers--Screening, knowledge, attitudes and behaviors related to alcohol interventions.

Geetanjali Chander, Anne K Monroe, Heidi M Crane, Heidi E Hutton, Michael S Saag, Karen Cropsey, Joseph J Eron, E Byrd Quinlivan, Elvin Geng, William Christopher Mathews and 6 more

Open access · greenAbstract read
In one paragraph

Article in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 37 papers.

0numbers the graph read from it
0cells of the map it votes in
37citing papers in PubMed
4.2field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

37 citing papers in PubMed, 45 citations in OpenAlex.

  1. Trial
  2. Trial
  3. Trial
  4. Trial
  5. Trial
  6. Trial
  7. Trial
  8. Trial
  9. Trial
  10. Article
  11. Article
  12. Article
  13. Review
  14. Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

16 authors at 8 institutions in 1 country.

Geetanjali ChanderDepartment of Medicine, The Johns Hopkins University School of Medicine, 1830 E. Monument Street, Baltimore, MD 21287, United States. Electronic address: Gchande1@jhmi.edu.
Anne K MonroeDepartment of Medicine, The Johns Hopkins University School of Medicine, 1830 E. Monument Street, Baltimore, MD 21287, United States. Electronic address: amonroe4@jhmi.edu.
Heidi M CraneDepartment of Medicine, Division of Infectious Disease, University of Washington, 325 9th Ave, NJB 1366 Box 359931, Seattle, WA 98104, United States. Electronic address: hcrane@uw.edu.
Heidi E HuttonDepartment of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway, Baltimore, MD 21205, United States. Electronic address: hhutton@jhmi.edu.
Michael S SaagDepartment of Internal Medicine, Division of Infectious Diseases, University of Alabama at Birmingham, Birmingham, AL. 1720 7th Ave S., Birmingham, AL 35294-0017, United States. Electronic address: msaag@uab.edu.
Karen CropseyDepartment of Psychiatry and Behavioral Neurobiology, University of Alabama at Birmingham, 1720 7th Ave S., Birmingham, AL 35294-0017, United States. Electronic address: kcropsey@uab.edu.
Joseph J EronDepartment of Medicine, Division of Infectious Disease, University of North Carolina, Chapel Hill CB# 7030, Bioinformatics Building, 130 Mason Farm Road, 2nd Floor, Chapel Hill, NC 27599-7030, United States. Electronic address: joseph_eron@med.unc.edu.
E Byrd QuinlivanDepartment of Medicine, Division of Infectious Disease, University of North Carolina, Chapel Hill CB# 7030, Bioinformatics Building, 130 Mason Farm Road, 2nd Floor, Chapel Hill, NC 27599-7030, United States. Electronic address: ebq@med.unc.edu.
Elvin GengDepartment of Medicine, University of California at San Francisco, 1001 Potrero Ave, SFGH 80, San Francisco, CA 94110, United States. Electronic address: genge@php.ucsf.edu.
William Christopher MathewsDepartment of Medicine, University of California San Diego, 200 W Arbor Dr # 140, San Diego, CA 92103, United States. Electronic address: cmathews@ucsd.edu.
Stephen BoswellDepartment of Medicine, Harvard University School of Medicine, Mass Fenway Community Health Ctr, 1340 Boylston St, Boston, MA 02215, United States. Electronic address: sboswell@fenwayhealth.org.
Benigno RodriquezDepartment of Medicine-Infectious Diseases, Case Western Reserve University, 111000 Euclid Ave, Cleveland, OH 44106, United States.
Megan EllisonDepartment of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway, Baltimore, MD 21205, United States. Electronic address: Ellison@jhmi.edu.
Mari M KitahataDepartment of Medicine, Division of Infectious Disease, University of Washington, 325 9th Ave, NJB 1366 Box 359931, Seattle, WA 98104, United States. Electronic address: kitahata@uw.edu.
Richard D MooreDepartment of Medicine, The Johns Hopkins University School of Medicine, 1830 E. Monument Street, Baltimore, MD 21287, United States. Electronic address: rdmoore@jhmi.edu.
Mary E McCaulDepartment of Psychiatry & Behavioral Sciences, The Johns Hopkins University School of Medicine, 550 N. Broadway, Baltimore, MD 21205, United States. Electronic address: mmccaul1@jhmi.edu.
Johns Hopkins Medicine · USJohns Hopkins University · USUniversity of Alabama at Birmingham · USUniversity of North Carolina at Chapel Hill · USUniversity of Washington · USCase Western Reserve University · USFenway Health · USUniversity of California, San Diego · US

Funding

Unsolicited R24 for the CFAR-Network of Integrated Clinical Sciences, CNICSR24AI067039 · NIAID · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI Michael S. Saag · 2006 to 2026
$99.4M
Virology, Immunology, and Microbiology CoreP30AI050410 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI DAVID M. MARGOLIS · 2001 to 2026
$76.9M
Vaccine Response and Immunotherapeutics SWGP30AI094189 · NIAID · JOHNS HOPKINS UNIVERSITY · PI Richard E. Chaisson · 2012 to 2026
$67.0M
Ujima Mentoring ProgramP30MH062246 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI Sheri Ann Lippman · 2001 to 2026
$57.4M
3/4 Alcohol Research Consortium in HIV - Epidemiological Research Arm (ARCH-ERA)U01AA020793 · NIAAA · UNIVERSITY OF WASHINGTON · PI CRANE, HEIDI M., LAU, BRYAN · 2011 to 2020
$5.8M
Integration of Evidence-based Alcohol Interventions into HIV CareU01AA020802 · NIAAA · UNIVERSITY OF ALABAMA AT BIRMINGHAM · PI CROPSEY, KAREN L, MUGAVERO, MICHAEL J · 2011 to 2020
$4.2M
1/4 Alcohol Research Consortium in HIV-Administrative Core (ARCH-AC)U24AA020801 · NIAAA · JOHNS HOPKINS UNIVERSITY · PI CHANDER, GEETANJALI, MCCAUL, MARY E · 2011 to 2021
$3.5M
Leveraging Patient-Reported Outcomes to Improve Retention in HIV CareK23MH105284 · NIMH · JOHNS HOPKINS UNIVERSITY · PI MONROE, ANNE KRESS · 2014 to 2016
$525k
NIAAA NIH HHS U01 AA020793NIAAA NIH HHS U01AA020793NIAAA NIH HHS U01 AA020802NIAAA NIH HHS U24 AA020801NIAAA NIH HHS U24AA020801NIAAA NIH HHS UO1AA020802NIAID NIH HHS P30 AI050410NIAID NIH HHS P30 AI094189NIAID NIH HHS R24 AI0667039NIAID NIH HHS R24 AI067039NIMH NIH HHS K23 MH105284NIMH NIH HHS K23MH105284-01NIMH NIH HHS P30 MH062246
6 · The paper itself

Abstract

backgroundAlcohol has particularly harmful health effects in HIV-infected patients; therefore, HIV clinics are an important setting for integration of brief alcohol intervention and alcohol pharmacotherapy to improve patient outcomes. Current practices of alcohol screening, counseling, and prescription of pharmacotherapy by HIV providers are unknown.

methodsWe conducted a cross-sectional survey of HIV providers from 8 HIV clinical sites across the United States. Surveys queried knowledge and use of alcohol screening, brief advice, counseling and pharmacotherapy, confidence and willingness to prescribe pharmacotherapy and barriers to their use of alcohol pharmacotherapy. We used multivariable logistic regression to examine provider factors associated with confidence and willingness to prescribe pharmacotherapy.

resultsProviders (N=158) were predominantly female (58%) and Caucasian (73%); almost half were infectious disease physicians and 31% had been in practice 10-20 years. Most providers (95%) reported always or usually screening for alcohol use, although only 10% reported using a formal screening tool. Over two-thirds never or rarely treated alcohol-dependent patients with pharmacotherapy themselves. Most (71%) referred alcohol-dependent patients for treatment. Knowledge regarding alcohol pharmacotherapy was low. The major barrier to prescribing pharmacotherapy was insufficient training on use of pharmacotherapy. Provider confidence ratings were positively correlated with their practice patterns.

conclusionsHIV providers reported high rates of screening for alcohol use, though few used a formal screening tool. Most providers referred alcohol dependent patients to outside resources for treatment. Few reported prescribing alcohol pharmacotherapy. Increased training on alcohol pharmacotherapy may increase confidence in prescribing and use of these medications in HIV care settings.

Indexed as

Health Knowledge, Attitudes, PracticePrimary Health CareAdultAlcohol DrinkingCounselingCross-Sectional StudiesFemaleHealth PersonnelHIV InfectionsHumansMaleMiddle AgedSurveys and QuestionnairesUnited StatesAlcohol screeningConfidenceEducationHIVKnowledge

Identifiers

PMID26857898
PMCPMC4841449
OpenAlexW2284168516

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.